Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;24(136):263-71.
doi: 10.1183/16000617.00000815.

Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension

Affiliations
Review

Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension

David Jenkins. Eur Respir Rev. 2015 Jun.

Abstract

Pulmonary endarterectomy (PEA) is the treatment of choice to relieve pulmonary artery obstruction in patients with chronic thromboembolic pulmonary hypertension (CTEPH). It is a complex surgical procedure with a simple principle: removal of obstructive thromboembolic material from the pulmonary arteries in order to reduce pulmonary vascular resistance, relieve pulmonary hypertension (PH) and alleviate right ventricular dysfunction. In the majority of patients there is symptomatic and prognostic benefit. However, not all patients with CTEPH are suitable for treatment with PEA. Operability assessment is not always easy, being largely subjective and based on experience. It is therefore important that all patients are referred to an experienced CTEPH centre for careful evaluation of suitability for surgery. The most common reason for inoperability is distal vasculopathy accounting for a high proportion of the vascular resistance. Surgery requires cardiopulmonary bypass and periods of deep hypothermic circulatory arrest. Complications include reperfusion lung injury and persistent PH. However, with careful patient selection, surgical technique and post-operative management, PEA is a highly effective treatment with mortality rates <5% at experienced centres. Patients who are unsuitable for surgery may be candidates for medical therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

Figures

FIGURE 1
FIGURE 1
Example scans for a typical patient with operable chronic thromboembolic pulmonary hypertension. a) Perfusion (Q′) and b) ventilation (V′) lung scans. R: right; L: left; ANT: anterior; POST: posterior; LPO: left posterior oblique; RPO: right posterior oblique. c) Computed tomography pulmonary angiography scan. d) Pulmonary angiogram.
FIGURE 2
FIGURE 2
a) Longitudinal incision in the right pulmonary artery, exposed between the superior vena cava and aorta. b) Developing the endarterectomy dissection plane in the left pulmonary artery. c) Removing the occluded endarterectomy “tails” from the left upper lobe segmental vessels.

References

    1. Galiè N, Hoeper MM, Humbert M, et al. . Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219–1263. - PubMed
    1. Kim NH, Delcroix M, Jenkins DP, et al. . Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D92–D99. - PubMed
    1. Hoeper MM, Madani MM, Nakanishi N, et al. . Chronic thromboembolic pulmonary hypertension. Lancet Respir Med 2014; 2: 573–582. - PubMed
    1. Madani MM, Auger WR, Pretorius V, et al. . Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012; 94: 97–103. - PubMed
    1. Dartevelle P, Fadel E, Mussot S, et al. . Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637–648. - PubMed

Publication types

MeSH terms

Substances